Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-01
2008-07-15
Eyler, Yvonne (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S151000, C544S097000
Reexamination Certificate
active
07399760
ABSTRACT:
Pyrimidinedione derivatives of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them are useful for the treatment of inflammation and immunological diseases.
REFERENCES:
patent: 4171429 (1979-10-01), Watanabe et al.
patent: 4495349 (1985-01-01), Skulnick et al.
patent: 4507302 (1985-03-01), Fast et al.
patent: 4593030 (1986-06-01), Skulnick et al.
patent: 4625028 (1986-11-01), Smith
patent: 5461060 (1995-10-01), Miyasaka et al.
patent: 7101873 (2006-09-01), Agarwal et al.
patent: 2003/0225075 (2003-12-01), Agarwal et al.
patent: 2142317 (1973-03-01), None
Andreichikov et al., Chemistry of oxalyl derivatives of methyl ketones. 40. Reaction of 5-aryl-2,3-dihydro-2,3-furandiones with aryl- and aroylcyanamides, Khimiya Geterotsiklicheskikh Soedinenii (1985), (2), 166-169, See Abstract.
Andreichikov et al. (2), Synthesis and antiinflammatory activity of 5-phenacylidene-2-imino-4-oxazolidones, Khimiko-Farmatsevticheskii Zhurnal (1989), 23(2), 157-160, See Abstract.
Skulnick et al., “Regiospecific Synthesis of N-1 and N-2 Substituted Pyrimidinones Employing a Novel 1,3-Oxazine Prepraration”, Heterocycles, vol. 23, No. 7, pp. 1685-1689 (1985).
Kamela, Journal f. Prakt. Chemie Band 324, Heft 1, 1982, S. 172-176.
Pelletier, et al., “Cytokines and Their Role in the Pathophysiology of Osteoarthritis,”Frontiers in Bioscience, 1999, 4, 694-703.
Rabinowitz, et al., “Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE),”J. Med. Chem., 2001, 44, 4252-4267.
Russo, et al., “TNF-α as a Promising Therapeutic Target in Chronic Asthma: a Lesson From Rheumatoid Arthritis,”Clinical Science, 2005, 109, 135-142.
Sakai, et al., “TNF-α Augments the Expression of RhoA in the Rat Bronchus,”J. Smooth Muscle Res., 2004, 40(1), 25-34.
Rana, et al., “Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women,”Diabetes Care, 2004, 27(10), 2478.
Agarwal Shiv Kumar
Aggarwal Pawan
Shivakumar Savithiri
Tadiparthi Ravikumar
Bexel Pharmaceuticals Inc.
Eyler Yvonne
Nwaonicha Chukwuma O
LandOfFree
Pyrimidinedione derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidinedione derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidinedione derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3970266